SLNO
Soleno Therapeutics
SLNO
SLNO
Delisted
SLNO was delisted on the 15th of May, 2026.
240 hedge funds and large institutions have $4.4B invested in Soleno Therapeutics in 2025 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 114 increasing their positions, 53 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $4.75B → $4.4B (-$351M)
12% less call options, than puts
Call options by funds: $154M | Put options by funds: $175M
25% less funds holding in top 10
Funds holding in top 10: 16 → 12 (-4)
Holders
240
Holding in Top 10
12
Calls
$154M
Puts
$175M
Top Buyers
| 1 | +$346M | |
| 2 | +$125M | |
| 3 | +$95M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$63.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$56.9M |
Top Sellers
| 1 | -$161M | |
| 2 | -$125M | |
| 3 | -$78.2M | |
| 4 |
CG
Carlyle Group
Washington,
District of Columbia
|
-$72.1M |
| 5 |
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Warszawa,
Poland
|
-$42.1M |